Surmodics, Inc. SRDX is well-poised for growth in the coming quarters, courtesy of its solid prospects in the thrombectomy business over the past few months. The optimism led by a solid second-quarter ...
Irvine medical device maker Endologix today announced its acquisition of the Pounce Thrombectomy System from Minnesota-based ...
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it has entered ...
Anyone interested in Surmodics, Inc. (NASDAQ:SRDX) should probably be aware that the Independent Director, David Dantzker, recently divested US$163k worth of shares in the company, at an average price ...
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 ...
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of June. At Insider ...
Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the ...
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq:SRDX - News), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that ...
The latest price target for Surmodics (NASDAQ:SRDX) was reported by Needham on April 30, 2025. The analyst firm set a price target for $0.00 expecting SRDX to fall to within 12 months (a possible -100 ...
Surmodics, Inc. (NASDAQ:SRDX) shares are trading lower in the premarket session on Friday. The firm’s stock dipped following news that the U.S. Federal Trade Commission will challenge the proposed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results